Discover more insights into Brca1 2 Pathogenic Brca1 2 병원성

Keywords frequently search together with Brca1 2 Pathogenic Brca1 2 병원성

Narrow sentence examples with built-in keyword filters


Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers



Germline testing in community oncology patients with somatic BRCA1/2 mutations.



Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.



Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.



Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy



Abstract PS8-29: Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer



Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study



A systematic review of psycho-social interventions for individuals with a BRCA1/2 pathogenic variant.



Spectrum of Germline Pathogenic Variants in BRCA1/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing



Germline and Tumor BRCA1/2 Pathogenic Variants in Chinese Triple-negative Breast Carcinomas



BRCA mutations and gastrointestinal cancers: When to expect the unexpected?



Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.



Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer



Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.



Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper



Homologous recombination deficiency associated with response to poly (ADP-ribose) polymerase inhibitors in ovarian cancer patients: The first real-word data from China.



Genetic counselor approaches to BRCA1/2 direct‐to‐consumer genetic testing results



Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability



Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome



Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice



Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas



“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”



Cancer-specific mortality associated with germline genetic testing results among women with breast cancer or ovarian cancer treated with chemotherapy.



Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers



Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation.



Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series



Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers



Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing


Learn more from Brca1 2 Pathogenic Brca1 2 병원성

Brca1 2 Pathogenic Brca1 2 병원성


Brca1 2 Pathogenic Brca1 2 병원성
Encyclopedia 백과사전